Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4069254 Title: FORMES POSOLOGIQUES ORALES SOLIDES COMPRENANT DE LA DECITABINE ET DE LA CÉDAZURIDINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
217618834
WO application number:
US2021019310
Type:
European patent granted for BE
Status:
Open
Publication number:
4069254
WO publication number:
WO2021173598
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
24/02/2021
Grant date:
11/09/2024
EP publication date:
12/10/2022
WO publication date:
02/09/2021
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
11/09/2024
EP B1 publication date:
11/09/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
24/02/2041

Applicant

Name:
Otsuka Pharmaceutical Co., Ltd.
Legal Form:
From:
11/09/2024
Address:
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, Japan (JP)
To:

Agent

Name:
GEVERS PATENTS
Legal Form:
From:
03/10/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:

Inventor

1

Name:
OGANESIAN, Aram
Legal Form:
Address:
Dublin, California 94568, United States (US)

2

Name:
DAVAR, Nipun
Legal Form:
Address:
Pleasanton, California 94566, United States (US)

3

Name:
KOU, Jim Hwaicher
Legal Form:
Address:
San Jose, California 95129, United States (US)

Priority

Priority patent number:
202062981304 P
Priority date:
25/02/2020
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/706; A61K 31/7068; A61P 35/00; A61P 35/02;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/17
Publication date:
04/11/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202437
Publication date:
11/09/2024
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
02/03/2026
Annual fee number:
6
Annual fee amount:
95 Euro
Expected payer:
Last annual fee payment date:
07/01/2025
Last annual fee paid number:
5
Last annual fee paid amount:
75 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
03/10/2024 Outgoing Correspondence 1 PDF /8/2/5/4/6/0722464528/docs/217618834_0_outgoingcorrespondence_20241005_084621132.pdf
03/10/2024 Incoming Correspondence (Email) Cover letter 1 PDF /8/2/5/4/6/0722464528/docs/217618834_1_incomingcorrespondenceelectronic_20241005_084621400.pdf
03/10/2024 General Document Declaration of domicile 1 PDF /8/2/5/4/6/0722464528/docs/217618834_2_generaldocument_20241005_084621273.pdf